Abstract:In this study, we introduced a NADPH derivative named as Nanoshutter (NS). NS was designed to inhibit the catalytic activity of NOS, i.e. synthesis of NO, by occupying the NADPH site in the reductase domain of NOS. In mammals, NO participates in extensive physiological/pathological processes in the cardiovascular, nervous and immune systems. The pathway of mammal NO synthesis is the oxidation of L-arginine catalyzed by NOS, which occurs in its oxygenase domain. The catalysis requires three co-substrates (L-arginine, NADPH, and O2) and five cofactors groups (FAD, FMN, calmodulin, BH4 and heme). Guided by molecular modeling, the structure of NS contains two conjugated subunits: (i) the nucleotide recognition motif of NADPH was retained in NS, allowing a proper targeting to the NADPH binding site of NOS- (ii) the nicotinamide moiety of NADPH is replaced by a stilbene moiety linked with a terminal electron acceptor group, preventing electron flow from the reductase to the oxygenase domain of NOS. Furthermore, this moiety is characterized by a large two-photon absorption cross-section (130 at 840 nm). NS1, the first compound of the NS family, contains a NO2 terminal group as an electron acceptor group. NS1 displayed distinct fluorescence properties in its free and NOS-bound states. The Kd value (around 4.2 µM) was estimated in titration experiments performed under one- or two-photon excitation conditions, suggesting an effective binding of NS1 to NOS with a good affinity. Surprisingly, in terms of fluorescence quantum yield, NS1 displayed a good selectivity to the NOS isoforms over other proteins which contain or not a NADPH binding site. Furthermore, NS1 was shown to competitively inhibit nNOS in a dose-dependent manner. In fluorescence imaging experiments with endothelial cells (HUVEC), NS1 displayed a rapid and efficient internalization, with highlighted fluorescence signal at the perinucleus region and sporadic signal at the plasma membrane. This observation was in accordance with the colocalization imaging between NS1 and eNOS as shown by immunostaining, showing that NS1 actually targets eNOS in endothelial cells. The expected NO-dependent vasoconstriction in isolated mouse aortic rings was only evidenced in the presence of catalase, which converts H2O2 into H2O and O2. By contrast, in the absence of catalase, a contradictory vasorelaxation was observed. This result indicates that NS1 may target more than NOS in endothelium system, which is (are) likely related to Reactive Oxygen Species (ROS) production. Accordingly, NS1 led to a biphasic response of ROS production in HUVEC cells: An increasing phase occurred at low NS1 concentration (below 2 µM) and followed by a decreasing phase (ROS inhibition) at higher NS1 concentrations. Furthermore, NS1 was shown to inhibit O2- production in mouse macrophages and H2O2 and O2- production in uncoupled nNOS in vitro. Altogether, the possible but not exclusive explanations for current data are: in addition to its inhibition effect on NO production, NS1 probably also inhibits the ROS production either produced by NADPH Oxidase or by electron leakage from uncoupled NOS, or a combination of both. The origin of the increasing phase remains more elusive but could correspond to the targeting of glucose-6-phosphate-dehydrogenase (G6PD). Additionally, NS1 displayed anti-angiogenesis effect on endothelial cells and prevented proliferation of melanoma. In conclusion, NS1 fulfilled the goal as a new NOS inhibitor targeting the reductase domain and displayed a unique two-photon property in vitro and in vivo, these features may provide a promising future for non-invasive real-time imaging, and to potential clinical applications in the NO-dependent diseases.

Inactivation Mechanism of Neuronal Nitric Oxide Synthase by (S)-2-amino-5-(2-(methylthio)acetimidamido)pentanoic Acid: Chemical Conversion of the Inactivator in the Active Site.

Crystallographic and Computational Insights into Isoform-Selective Dynamics in Nitric Oxide Synthase

The Molecular Simulation Study of nNOS Activation Induced by the Interaction Between Its Calmodulin-Binding Domain and SUMO1

Ab Initio Molecular Metadynamics Simulation for S-nitrosylation by Nitric Oxide: S-nitroxide As the Key Intermediate

Regulation of the Monomer-Dimer Equilibrium in Inducible Nitric-oxide Synthase by Nitric Oxide

[Dynamin-Mediated Endocytic Process Contributes to Neuronal Nitric Oxide Synthase-Mediated Regulation of Cardiac Contraction].

Restricting the conformational freedom of the neuronal nitric-oxide synthase flavoprotein domain reveals impact on electron transfer and catalysis

Inhibition of skeletal muscle S1-myosin ATPase by peroxynitrite

Mechanism of Inhibition of the Human Sirtuin Enzyme SIRT3 by Nicotinamide: Computational and Experimental Studies

Mechanistic Analysis Of A Suicide Inactivator Of Histone Demethylase Lsd1

Electrochemically Driven Biocatalysis of the Oxygenase Domain of Neuronal Nitric Oxide Synthase in Indium Tin Oxide Nanoparticles/polyvinyl Alcohol Nanocomposite.

Ligand-Protein Interactions In Mammalian Nitric Oxide Synthase

Étude D'un Nouveau Composé À Propriété D'absorption Multiphotonique Dérivé Du NADPH Ciblant La NO-synthase

Nitric oxide inhibition of the rat olfactory cyclic nucleotide-gated cation channel

Protein Tyrosine Nitration and Thiol Oxidation by Peroxynitrite—Strategies to Prevent These Oxidative Modifications

Abstract 18583: Posttranslational Modification of Sirt6 Activity by Reactive Nitrogen Species

Effects and mechanism of action of inducible nitric oxide synthase on apoptosis in a rat model of cerebral ischemia-reperfusion injury.

Oxidative Modification of Neurogranin by Nitric Oxide: an Amperometric Study

Insights into human eNOS, nNOS and iNOS structures and medicinal indications from statistical analyses of their interactions with bound compounds

NO Generation from Nitrite at Zinc(II): Role of Thiol Persulfidation in the Presence of Sulfane Sulfur

[Progress in the Studies on Neuronal Nitric Oxide Synthase Inhibitors].